GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

Unicocell Biomed Co 6794.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

65.00

+0.78%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 30.1m

FY2017FY2025

Net income

−TWD 114.8m

FY2017FY2025

Free cash flow

−TWD 96.8m

FY2017FY2025

Shareholders' equity

TWD 865.4m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueTWD 30.1mTWD 31.9mTWD 24.6mTWD 14.4mTWD 8.2mTWD 4.0mTWD 15.7mTWD 5.5mTWD 6.0m
Research and developmentTWD 92.4mTWD 88.6mTWD 82.8mTWD 74.9mTWD 69.9mTWD 91.8mTWD 93.5mTWD 66.2mTWD 49.2m
Operating income−TWD 130.3m−TWD 102.9m−TWD 96.3m−TWD 92.1m−TWD 87.3m−TWD 108.3m−TWD 101.0m−TWD 69.0m−TWD 44.2m
Net income−TWD 114.8m−TWD 93.1m−TWD 84.1m−TWD 91.2m−TWD 86.4m−TWD 109.2m−TWD 100.9m−TWD 40.5m−TWD 42.9m
Diluted earnings per share-1.89-1.57-1.52-2.15-2.29-2.91-3.15-2.51-3.94

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsTWD 946.0mTWD 777.9mTWD 685.9mTWD 414.3mTWD 297.7mTWD 391.2mTWD 356.2mTWD 286.1mTWD 141.5m
Cash and short-term investmentsTWD 752.0mTWD 553.5mTWD 477.3mTWD 213.9mTWD 141.0mTWD 232.1mTWD 235.9mTWD 253.0mTWD 122.9m
Total liabilitiesTWD 80.6mTWD 93.3mTWD 89.5mTWD 80.5mTWD 34.7mTWD 47.8mTWD 61.9mTWD 13.1mTWD 4.2m
DebtTWD 6.3mTWD 68.2mTWD 74.3mTWD 66.6mTWD 21.6mTWD 10.2mTWD 9.9m——
Shareholders' equityTWD 865.4mTWD 684.6mTWD 596.4mTWD 333.9mTWD 263.0mTWD 343.4mTWD 294.3mTWD 273.0mTWD 137.3m
Shares outstanding61m59m56m42m38m38m32m16m11m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−TWD 91.3m−TWD 61.5m−TWD 65.5m−TWD 63.6m−TWD 61.7m−TWD 92.2m−TWD 77.2m−TWD 58.0m−TWD 42.4m
Capital spending−TWD 5.5m−TWD 5.7m−TWD 16.0m−TWD 14.6m−TWD 24.0m−TWD 56.8m−TWD 50.8m−TWD 10.4m−TWD 1.9m
Free cash flow−TWD 96.8m−TWD 67.2m−TWD 81.5m−TWD 78.2m−TWD 85.7m−TWD 149.0m−TWD 127.9m−TWD 68.4m−TWD 44.3m

Financial ratios

Data as of 14 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-432.8%-287.3%-336.2%-624.4%-1048.3%-2718.9%
Net margin-381.5%-291.9%-342.1%-633.2%-1056.3%-2742.6%
Return on equity-13.3%-13.6%-14.1%-27.3%-32.8%-31.8%
Return on assets-12.1%-12.0%-12.3%-22.0%-29.0%-27.9%
Free cash flow yield-2.0%-1.4%-1.3%-1.7%-1.4%-1.4%
Revenue growth-5.6%29.7%70.8%76.1%105.3%-74.7%
Earnings growth23.4%10.7%-7.7%5.5%-20.9%8.2%
Current ratio37.98x21.83x29.99x14.38x7.64x10.83x
Debt to equity0.01x0.01x0.01x0.02x0.03x0.03x
Equity ratio91.5%88.0%87.0%80.6%88.3%87.8%
Interest coverage-97.29x-62.44x-56.93x-71.58x-130.67x-114.69x
R&D as a share of sales307.1%278.0%336.7%520.3%854.5%2304.2%
Buybacks as a share of market value-2.6%-6.9%-31.0%-12.2%-0.6%-17.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue27.9%49.9%—
Operating income12.3%3.8%—
Net income8.0%1.0%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-47.5-43.5-54.5-14.9-18.8-14.1
Price to sales181.3127.1186.594.2198.5385.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.